HALOZYME THERAPEUTICS INC Business Finance Contracts & Agreements
50 Contracts & Agreements
- Credit Agreements (4 contracts)
- Indenture Agreements (3)
- Loan Agreements (8)
- Note Agreements (2)
- Purchase Agreements (3)
- Security Agreements (1)
- Stock Agreements (25)
- Underwriting Agreements (4)
- Form of Director Stock Option Agreement (2021 Plan) (Filed With SEC on August 8, 2023)
- Form of Restricted Stock Unit Agreement (2021 Plan updated May 2023) (Filed With SEC on August 8, 2023)
- Form of Stock Option Agreement (2021 Plan updated May 2023) (Filed With SEC on August 8, 2023)
- Amendment No. 2 to the Credit Agreement (Filed With SEC on May 9, 2023)
- Halozyme Therapeutics, Inc. 2021 Employee Stock Purchase Plan (Filed With SEC on November 8, 2022)
- Amendment No. 1 to the Credit Agreement (Filed With SEC on August 19, 2022)
- Indenture, dated August 18, 2022 between Halozyme Therapeutics, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (Filed With SEC on August 18, 2022)
- Security Agreement, dated as of May 24, 2022, by and among Halozyme Therapeutics, Inc., the Guarantors and Bank of America N.A (Filed With SEC on May 24, 2022)
- Credit Agreement, dated as of May 24, 2022, by and among Halozyme Therapeutics, Inc., the Guarantors, Bank of America N.A. and each of those additional Lenders that are a party to... (Filed With SEC on May 24, 2022)
- Form of Restricted Stock Units Agreement for Irish Participants (2021 Stock Plan) (Filed With SEC on August 9, 2021)
- Form of Director Restricted Stock Units Agreement (2021 Stock Plan) (Filed With SEC on May 5, 2021)
- Form of Restricted Stock Award Agreement (2021 Stock Plan) (Filed With SEC on May 5, 2021)
- Form of Restricted Stock Units Agreement (2021 Stock Plan) (Filed With SEC on May 5, 2021)
- Form of Restricted Stock Units Agreement for Officers (2021 Stock Plan) (Filed With SEC on May 5, 2021)
- Form of Stock Option Agreement (2021 Stock Plan) (Filed With SEC on May 5, 2021)
- Halozyme Therapeutics, Inc. 2021 Stock Plan (Filed With SEC on May 5, 2021)
- Halozyme Therapeutics, Inc. 2021 Employee Stock Purchase Plan (Filed With SEC on May 5, 2021)
- Form of Note, dated March 1, 2021 between Halozyme Therapeutics, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (Filed With SEC on March 1, 2021)
- Indenture, dated March 1, 2021 between Halozyme Therapeutics, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (Filed With SEC on March 1, 2021)
- Indenture, dated November 18, 2019 between Halozyme Therapeutics, Inc. and The Bank of New York Mellon Trust Company, N.A, as trustee (Filed With SEC on November 18, 2019)
- Form of Note, dated November 18, 2019 between Halozyme Therapeutics, Inc. and The Bank of New York Mellon Trust Company, N.A, as trustee (Filed With SEC on November 18, 2019)
- Third Amendment to Loan and Security Agreement between Oxford, SVB and Registrant, dated June 14, 2019 (Filed With SEC on August 6, 2019)
- Halozyme Therapeutics, Inc. 2011 Stock Plan, as proposed to be amended (Filed With SEC on April 6, 2018)
- Consent, Release, and Second Amendment to Loan and Security Agreement, dated November 21, 2017 (Filed With SEC on February 20, 2018)
- HALOZYME THERAPEUTICS, INC. 10,000,000 Shares of Common Stock, par value $0.001 per share Underwriting Agreement (Filed With SEC on May 19, 2017)
- CONSENT, RELEASE, AND FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on February 28, 2017)
- HALOZYME THERAPEUTICS, INC. RESTRICTED STOCK UNITS AGREEMENT UNDER THE HALOZYME THERAPEUTICS, INC. 2011 STOCK PLAN (Filed With SEC on February 28, 2017)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on August 9, 2016)
- CREDIT AGREEMENT Dated as of December , 2015 (Filed With SEC on February 29, 2016)
- CONSENT, RELEASE AND THIRD AMENDMENT TO AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (Filed With SEC on February 29, 2016)
- HALOZYME THERAPEUTICS, INC. RESTRICTED STOCK UNITS AGREEMENT UNDER THE HALOZYME THERAPEUTICS, INC. 2011 STOCK PLAN (Filed With SEC on November 9, 2015)
- HALOZYME THERAPEUTICS, INC. RESTRICTED STOCK AWARD AGREEMENT UNDER THE HALOZYME THERAPEUTICS, INC. 2011 STOCK PLAN (Filed With SEC on November 9, 2015)
- HALOZYME THERAPEUTICS, INC. STOCK OPTION AGREEMENT (Filed With SEC on November 9, 2015)
- HALOZYME THERAPEUTICS, INC. RESTRICTED STOCK AWARD AGREEMENT UNDER THE HALOZYME THERAPEUTICS, INC. 2011 STOCK PLAN (Filed With SEC on August 10, 2015)
- HALOZYME THERAPEUTICS, INC. RESTRICTED STOCK UNITS AGREEMENT UNDER THE HALOZYME THERAPEUTICS, INC. 2011 STOCK PLAN (Filed With SEC on August 10, 2015)
- HALOZYME THERAPEUTICS, INC. 2011 STOCK PLAN (as amended through May 6, 2015) (Filed With SEC on August 10, 2015)
- SECOND AMENDMENT TO AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT AND FIRST AMENDMENT TO DISBURSEMENT LETTER (Filed With SEC on March 2, 2015)
- CONSENT AND FIRST AMENDMENT TO AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (Filed With SEC on August 11, 2014)
- AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (Filed With SEC on February 28, 2014)
- HALOZYMETHERAPEUTICS, INC. 7,692,307 Shares of Common Stock, par value $0.001 per share Underwriting Agreement (Filed With SEC on February 5, 2014)
